Choose License Type
The global alpha amylase market size was valued at USD 274.1 million in 2017. The usage of enzymes in producing a wide range of products such as bakery goods, detergent and animal feed is the primary driver for the growth of the overall market. Moreover, the growing demand for convenience food in the developing countries is expected to accelerate the growth of alpha-amylase market globally over the forecast period.
Furthermore, alpha-amylase provides numerous features such as dough improvement, continued softness and tremendous color texture in food processing of cake, cookies and bread. This is expected to remain a favorable factor over the forecast period. Further, escalating demand for bakery products in the developed economies such as U.S., Canada, Germany, France and the United Kingdom is the primary factor which has increased the demand for overall alpha-amylase market. In addition, new frozen food products launched by Grupo Bimbo and Kellogg Company such as Pan Tipo Artesano and Rustic Rolls respectively have accelerated the demand for enzymes in food industry and is anticipated to drive the market in the coming years.
Alpha-amylase enzymes are made up of protein, which is used for increasing the production of maltose and glucose. The enzymes find its wide application in animal feed, sugar preservative products, bakery goods, biofuels, breweries, laboratory research and detergents. Bakery makers use these enzymes to increase the yeast yield and offer excellent texture to the dough during the preparation of the final product.
Bread segment dominated the global alpha amylase market and accounted for more than 60% of overall consumption in the year 2017. Alpha-amylase is extensively used for improving the quality and enhancing of dough preparation for bread and whole grains. The product finds its usage in biscuits & cookies for hydrolyzing the gluten structure to such an extent that the dough becomes firm and brings smooth layer which reduces the contraction from the dough. Moreover, increasing demand for bread from developed countries such as the U.S. and Germany are expected to drive the global demand for the alpha-amylase. On account of providing excellent texture, alpha-amylase is also used in huge volume for the formulation of pies, cakes, donuts and pastries.
Maltogenic dominated the global alpha amylase market in 2017 due to its wide application in the baking process. This enzymes are a stimulating alternative to chemical flavors and they are used in food processing. They are generally recognized as a safe chemical as they do not remain active in the finished product. Furthermore, maltogenic alpha-amylase is also applied in the baking of bread to enable the hydrolysis of amylopectin that is crystallizable in nature, and also for preventing the issue of recrystallization (retrogradation) during its storage. This conserves the soft crumb characteristics of the baked food product thereby increasing its shelf life
In 2017, North America was the largest market, accounting for 33.5 thousand tons in the global alpha amylase market. High dominance of bread manufacturing companies including Nature’s Own and Sara Lee Corporation is expected to have a considerable impact on the enzyme industry in this region. Additionally, the launch of new frozen bread, cakes and cookies in the United States and Canada is likely to increase the adoption of the enzymes over the forecast period.
The competitive landscape of the alpha-amylase market is highly fragmented. In September 2016, Novozymes announced the acquisition of Organobalance GmbH a German-based microbial research company. The company owns a huge collection of microbial enzymes and has strong capabilities assay technology and in microbial screening. The merger has strengthened the global presence of both the companies as they both specialize in manufacturing natural microbial solutions and chemicals for their global customers and partners across a number of industries including feed, food and animal health.
The global alpha amylase market includes various global and regional players such as Biolaxi Corporation, Novozymes, Calzyme, Inc, Enmex, Danisco, BASF Enzymes LLC, DSM, Amano Enzyme Inc., AB Enzymes and Suzhou Sino Enzymes.
Key segments of the global alpha amylase market
Source Overview, 2015-2025 (USD million) (Tons)
Application Overview, 2015-2025 (USD million) (Tons)
Regional Overview, 2015-2025 (USD million) (Tons)
Reasons for the study
What does the report include?
Who should buy this report?
The global alpha amylase market size was valued at USD 274.1 million in 2017. The usage of enzymes in producing a wide range of products such as bakery goods, detergent and animal feed is the primary driver for the growth of the overall market. Moreover, the growing demand for convenience food in the developing countries is expected to accelerate the growth of alpha-amylase market globally over the forecast period.
Furthermore, alpha-amylase provides numerous features such as dough improvement, continued softness and tremendous color texture in food processing of cake, cookies and bread. This is expected to remain a favorable factor over the forecast period. Further, escalating demand for bakery products in the developed economies such as U.S., Canada, Germany, France and the United Kingdom is the primary factor which has increased the demand for overall alpha-amylase market. In addition, new frozen food products launched by Grupo Bimbo and Kellogg Company such as Pan Tipo Artesano and Rustic Rolls respectively have accelerated the demand for enzymes in food industry and is anticipated to drive the market in the coming years.
Alpha-amylase enzymes are made up of protein, which is used for increasing the production of maltose and glucose. The enzymes find its wide application in animal feed, sugar preservative products, bakery goods, biofuels, breweries, laboratory research and detergents. Bakery makers use these enzymes to increase the yeast yield and offer excellent texture to the dough during the preparation of the final product.
Bread segment dominated the global alpha amylase market and accounted for more than 60% of overall consumption in the year 2017. Alpha-amylase is extensively used for improving the quality and enhancing of dough preparation for bread and whole grains. The product finds its usage in biscuits & cookies for hydrolyzing the gluten structure to such an extent that the dough becomes firm and brings smooth layer which reduces the contraction from the dough. Moreover, increasing demand for bread from developed countries such as the U.S. and Germany are expected to drive the global demand for the alpha-amylase. On account of providing excellent texture, alpha-amylase is also used in huge volume for the formulation of pies, cakes, donuts and pastries.
Maltogenic dominated the global alpha amylase market in 2017 due to its wide application in the baking process. This enzymes are a stimulating alternative to chemical flavors and they are used in food processing. They are generally recognized as a safe chemical as they do not remain active in the finished product. Furthermore, maltogenic alpha-amylase is also applied in the baking of bread to enable the hydrolysis of amylopectin that is crystallizable in nature, and also for preventing the issue of recrystallization (retrogradation) during its storage. This conserves the soft crumb characteristics of the baked food product thereby increasing its shelf life
In 2017, North America was the largest market, accounting for 33.5 thousand tons in the global alpha amylase market. High dominance of bread manufacturing companies including Nature’s Own and Sara Lee Corporation is expected to have a considerable impact on the enzyme industry in this region. Additionally, the launch of new frozen bread, cakes and cookies in the United States and Canada is likely to increase the adoption of the enzymes over the forecast period.
The competitive landscape of the alpha-amylase market is highly fragmented. In September 2016, Novozymes announced the acquisition of Organobalance GmbH a German-based microbial research company. The company owns a huge collection of microbial enzymes and has strong capabilities assay technology and in microbial screening. The merger has strengthened the global presence of both the companies as they both specialize in manufacturing natural microbial solutions and chemicals for their global customers and partners across a number of industries including feed, food and animal health.
The global alpha amylase market includes various global and regional players such as Biolaxi Corporation, Novozymes, Calzyme, Inc, Enmex, Danisco, BASF Enzymes LLC, DSM, Amano Enzyme Inc., AB Enzymes and Suzhou Sino Enzymes.
Key segments of the global alpha amylase market
Source Overview, 2015-2025 (USD million) (Tons)
Application Overview, 2015-2025 (USD million) (Tons)
Regional Overview, 2015-2025 (USD million) (Tons)
Reasons for the study
What does the report include?
Who should buy this report?
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunity
Chapter 4. Alpha Amylase Market Overview, By Source
4.1. Global alpha amylase market share, by source, 2017 & 2025
4.2. Fungi
4.2.1. Global fungi alpha amylase market, 2015 – 2025
4.3. Maltogenic
4.3.1. Global maltogenic alpha amylase market, 2015 – 2025
4.4. G4
4.4.1. Global G4 alpha amylase market, 2015 - 2025
4.5. Others
4.5.1. Global others alpha amylase market, 2015 - 2025
Chapter 5. Alpha Amylase Market Overview, By Application
5.1. Global alpha amylase market share, by application, 2017 & 2025
5.2. Bread
5.2.1. Global alpha amylase market for bread 2015 - 2025
5.3. Cookies & Biscuits
5.3.1. Global alpha amylase market for cookies & biscuits 2015 – 2025
5.4. Desserts
5.4.1. Global alpha amylase market for desserts 2015 – 2025
5.5. Others
5.5.1. Global alpha amylase market for other applications 2015 – 2025
Chapter 6. Alpha Amylase Market Overview, By Region
6.1. Global alpha amylase market share, by regions, 2017 & 2025
6.2. North America
6.2.1. North America alpha amylase market 2015 – 2025
6.2.2. North America alpha amylase market, by source 2015 – 2025
6.2.3. North America alpha amylase market, by application 2015 - 2025
6.2.4. U.S.
6.2.4.1. U.S. alpha amylase market 2015 - 2025.
6.3. Europe
6.3.1. Europe alpha amylase market 2015 – 2025
6.3.2. Europe alpha amylase market, by source 2015 – 2025
6.3.3. Europe alpha amylase market, by application 2015 - 2025
6.3.4. UK
6.3.4.1. U.K. alpha amylase market 2015 - 2025
6.3.5. Germany
6.3.5.1. Germany alpha amylase market 2015 – 2025
6.4. Asia Pacific
6.4.1. Asia Pacific alpha amylase market 2015 – 2025
6.4.2. Asia Pacific alpha amylase market, by source 2015 – 2025
6.4.3. Asia Pacific alpha amylase market, by application 2015 - 2025
6.4.4. China
6.4.4.1. China alpha amylase market 2015 - 2025
6.4.5. India
6.4.5.1. India alpha amylase market 2015 - 2025
6.5. Central & South America
6.5.1. Central & South America alpha amylase market 2015 – 2025
6.5.2. Central & South America alpha amylase market, by source 2015 – 2025
6.5.3. Central & South America alpha amylase market, by application 2015 - 2025
6.5.4. Brazil
6.5.4.1. Brazil alpha amylase market 2015 - 2025
6.6. Middle East & Africa
6.6.1. Middle East & Africa alpha amylase market 2015 – 2025
6.6.2. Middle East & Africa alpha amylase market, by source 2015 – 2025
6.6.3. Middle East & Africa alpha amylase market, by application 2015 - 2025
Chapter 7. Company Profiles
7.1. Biolaxi Corporation
7.1.1. Company overview
7.1.2. Product offerings
7.1.3. Financial performance
7.1.4. Recent initiatives
7.2. Novozymes
7.2.1. Company overview
7.2.2. Product offerings
7.2.3. Financial performance
7.2.4. Recent initiatives
7.3. Calzyme Inc,
7.3.1. Company overview
7.3.2. Product offerings
7.3.3. Financial performance
7.3.4. Recent initiatives
7.4. Enmex
7.4.1. Company overview
7.4.2. Product offerings
7.4.3. Financial performance
7.4.4. Recent initiatives
7.5. Danisco
7.5.1. Company overview
7.5.2. Product offerings
7.5.3. Financial performance
7.5.4. Recent initiatives
7.6. BASF Enzymes LLC
7.6.1. Company overview
7.6.2. Product offerings
7.6.3. Financial performance
7.6.4. Recent initiatives
7.7. DSM
7.7.1. Company overview
7.7.2. Product offerings
7.7.3. Financial performance
7.7.4. Recent initiatives
7.8. Amano Enzyme Inc.
7.8.1. Company overview
7.8.2. Product offerings
7.8.3. Financial performance
7.8.4. Recent initiatives
7.9. AB Enzymes
7.9.1. Company overview
7.9.2. Product offerings
7.9.3. Financial performance
7.9.4. Recent initiatives
7.10. Suzhou Sino Enzymes
7.10.1. Company overview
7.10.2. Product offerings
7.10.3. Financial performance
7.10.4. Recent initiatives